Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-027363
Filing Date
2018-10-24
Accepted
2018-10-24 16:27:12
Documents
1
Period of Report
2018-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6448
  Complete submission text file 0000899243-18-027363.txt   7870
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130
Business Address
YOUNG TODD S. (Reporting) CIK: 0001682584 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 181136696